Travere Therapeutics, Inc. has grown revenue 70% a year over three years and 24% a year over five. Revenue growth, 3-year annual rate: +70% (Biotechnology median +21%). Revenue growth, 5-year rate: +24%, growth has picked up over the last three years. Years of annual history on file: 16, FY2010 to FY2025, as filed.

TVTXTravere Therapeutics, Inc.

HealthcareUSD

$67.12

$16.9452 weeks$67.12

Is it growing?

Is TVTX growing?

Travere Therapeutics, Inc. has grown revenue 70% a year over three years and 24% a year over five.

+70%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +24%
Revenue growth, 5-year rate · +70% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›